CTEV customers relationship map

Claritev (CTEV): Payor relationships that define revenue predictability and regulatory risk

Claritev is a technology-enabled services firm that sells out-of-network cost management, payment and revenue-integrity solutions to U.S. payors and plan sponsors. The company monetizes through a blend of subscription and usage-based arrangements — including per-member-per-month licensing, bundled PEPM services, and percentage-of-savings (PSAV) commissions on claim recoveries — with a client base concentrated among large health plans, ASOs/TPAs and government payors. For investors assessing Claritev’s customer franchise, the combination of high enterprise concentration, variable PSAV economics, and multi-year contracting for large clients is the central lens for valuation and risk. Learn more on our homepage: https://nullexposure.com/

How the client footprint drives cash flow and risk

Claritev’s business model intentionally mixes predictable recurring revenue (subscription/PEPM) with variable, performance-linked revenue (PSAV). That structure delivers upside through success-based fees while concentrating operational and audit risk in the variable component. The company reports material customer concentration — two clients accounted for 28% and 16% of 2024 revenue — which amplifies revenue volatility if a large client contract lapses or renegotiates pricing.

Geographically, the business is national: Claritev derives essentially all revenue from U.S. operations and offers services in all 50 states and DC, so regulatory and payor dynamics are U.S.-centric. The client base includes federal and state-sponsored plans in addition to commercial insurers, positioning Claritev as a strategic vendor to both public and private payors.

Contracting posture, maturity and criticality — why it matters for investors

Claritev uses a hybrid contracting model: large clients typically sign multi-year agreements (three to five years), while mid-to-small accounts often have annual terms with automatic renewals. That structure supports revenue visibility for larger accounts while keeping a broad base of short-term, auto-renewing customers.
Subscription and licensing revenues increase predictability; PSAV revenue is variable and recognized based on management estimates, which was identified as a Critical Audit Matter by auditors due to judgment around estimating variable consideration.
The company positions itself as a service provider and transaction processor, not a payer or clinical provider, which constrains regulatory exposure to payment and data governance rather than direct care delivery.
Operationally, Claritev is highly concentrated toward large enterprise payors and government clients, which strengthens customer stickiness but increases single-counterparty risk.

These characteristics create a clear trade-off for investors: material upside from success-based fees and deep enterprise relationships, counterbalanced by estimation risk, large-client concentration and exposure to legal or payor-conduct developments.

Customer relationships in the public record

Below are every customer-related mention found in public coverage in the provided results, with short plain-English summaries and source citations.

Cigna — The Fierce Healthcare litigation coverage references Cigna as one of several insurers involved with platforms that calculate out-of-network rates and negotiate rates with providers; providers in the litigation allege coordination between insurers and platform operators. (Fierce Healthcare, March 9, 2026: https://www.fiercehealthcare.com/payers/judge-denies-multiplan-payers-motions-toss-price-fixing-litigation)
Elevance Health — The same Fierce Healthcare article lists Elevance Health among large payors using out-of-network rate-calculation platforms and related negotiation services, which are central to ongoing provider suits alleging rate suppression. (Fierce Healthcare, March 9, 2026: https://www.fiercehealthcare.com/payers/judge-denies-multiplan-payers-motions-toss-price-fixing-litigation)
UNH (ticker UNH) — Coverage identifies UnitedHealth Group as a codefendant insurer named in complaints tied to platforms that set out-of-network rates and engage third-party negotiators, illustrating sector-level regulatory and litigation exposure that affects vendors and their relationships with major payors. (Fierce Healthcare, March 9, 2026: https://www.fiercehealthcare.com/payers/judge-denies-multiplan-payers-motions-toss-price-fixing-litigation)
UnitedHealth Group — The article repeats references to UnitedHealth Group in describing provider suits against payors and platform operators; this duplication in public reporting highlights that Claritev’s payor clients operate in a highly scrutinized part of the market. (Fierce Healthcare, March 9, 2026: https://www.fiercehealthcare.com/payers/judge-denies-multiplan-payers-motions-toss-price-fixing-litigation)
Aetna (CVS) — Aetna is also named among insurers connected to platforms and services that calculate and negotiate out-of-network rates, a focal point for recent antitrust and provider litigation. (Fierce Healthcare, March 9, 2026: https://www.fiercehealthcare.com/payers/judge-denies-multiplan-payers-motions-toss-price-fixing-litigation)

Each of the above mentions comes from the same March 2026 Fierce Healthcare article, which reports on litigation involving rate-calculation platforms and payer relationships; investors should treat these as sector-level signals that inform Claritev’s operating environment rather than direct evidence of contractual disputes between Claritev and these specific payors.

What the constraints and disclosures tell investors

The disclosure-driven constraints give an operational profile you can act on:

Contract mix: The company explicitly runs both long-term multi-year contracts with large clients and annual contracts with automatic renewals for smaller clients, supporting a layered revenue book that blends visibility and flexibility.
Pricing mechanics: Subscription and PEPM licensing are a stated growth objective; PSAV arrangements are fully variable and recognized with significant managerial judgment, creating earnings volatility and audit focus.
Counterparty mix: Claritev serves government payors alongside large commercial insurers and ASO platforms, which increases the strategic importance of the business but also exposes Claritev to public-sector procurement cycles and compliance scrutiny.
Materiality and concentration: Two clients represented 28% and 16% of 2024 revenue, a concentration that makes contract renewals with those accounts a valuation-sensitive event.
Service orientation: The company is a technology-enabled services provider and transaction processor, not a clinical care operator; the primary risks are contractual, regulatory, and earnings-estimation related rather than clinical.

Together these signals indicate a business that is mature in its enterprise relationships, strategically critical to large payors, and operationally sensitive to revenue-recognition and legal developments.

Investment implications and risk checklist

Upside drivers: deep penetration of large U.S. payors, recurring subscription shift that improves predictability, and performance-based fees that scale with cost recovery.
Principal risks: revenue concentration, PSAV estimation and audit risk, and sector litigation/regulatory activity tied to how out-of-network pricing and negotiation services are structured.
Financial context: Claritev reported roughly $965 million in trailing revenue with strong gross profitability; investors should focus on contract renewals with the largest clients and the trend toward subscription revenue as key signals for forward valuation.

For a concise view of Claritev’s relationship signals and implications for portfolio modeling, visit https://nullexposure.com/ to access our research tools and relationship analytics.

Bold takeaway: Claritev combines enterprise-grade client penetration with variable, performance-linked economics, creating a profitable but concentration- and estimate-sensitive revenue profile that investors must monitor at the contract and legal-policy levels.